Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase subunit VIc pseudogene 12 (COX6CP12) is a processed pseudogene in the human genome. It is derived from the gene coding for the cytochrome c oxidase subunit VIc, a small nuclear-encoded component of cytochrome c oxidase (complex IV of the mitochondrial electron transport chain). However, as a pseudogene, COX6CP12 does not produce a functional protein; it is regarded as a non-coding genetic element arising via retrotransposition and subsequent mutation that lost coding potential. Pseudogenes like COX6CP12 can play regulatory roles at the RNA level, but are not considered functional targets for drug development or therapeutic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit VIc pseudogene 12 (COX6CP12).